Source Natural Foods & Herbal Supplements Ltd
₹108.50
(-2.34%)
Wed, 01 Apr 2026, 00:07 pm
Health Technology
Pharmaceuticals: Other
24.5KSource Natural Foods & Herbal Supplements Price to Sales Ratio (P/S)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 13.24 | 31.18 | 53.85 | 57.73 | 60.11 | 88.31 | 27.44 | 28.38 | 28.24 | 25.14 | 26.98 | 32.68 | 46.14 |
| Price to book ratio | 2.08 | 3.33 | 3.28 | 3.19 | 1.96 | 1.06 | 1.66 | 4.41 | 12.11 | 9.08 | 3.20 | 4.75 | 7.24 | 3.92 | 3.23 | 2.92 | 5.99 |
| Price to sales ratio | 6.41 | 38.47 | 19.61 | 4.23 | 1.26 | 1.19 | 1.31 | 2.25 | 5.29 | 6.50 | 2.20 | 3.42 | 3.83 | 2.84 | 2.89 | 2.08 | 2.98 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 9.58 | 27.88 | 23.21 | 65.49 | 0 | 0 | 11.36 | 0 | 22.06 | 0 | 25.13 | 22.69 | 0 |
| Enterprise value | 42.18M | 127.86M | 97.96M | 82.89M | 62.56M | 47.09M | 79.05M | 238.23M | 860.67M | 722.35M | 275.68M | 476.43M | 934.94M | 603.19M | 543.34M | 508.89M | 1.34B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 10.87 | 13.19 | 11.20 | 24.73 | 44.15 | 51.15 | 15.26 | 19.11 | 19.16 | 15.81 | 15.06 | 11.37 | 26.08 |
| Debt to equity ratio | 4.46 | 0.12 | 0.37 | 0.99 | 0.92 | 0 | 0.02 | 0.01 | 0.27 | 0.23 | 0.02 | 0.11 | 0.07 | 0 | 0 | 0.06 | 0.33 |
| Return on equity % | 0 | -31.55 | -38.78 | -27.39 | 15.91 | 4.62 | 3.10 | 7.98 | 22.42 | 10.87 | 12.40 | 17.65 | 29.40 | 16.92 | 12.73 | 9.34 | 13.89 |
Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio
The Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Source Natural Foods & Herbal Supplements Ltd's valuation, profitability, and overall financial performance. Tracking the Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Source Natural Foods & Herbal Supplements Ltd (NSE: , BSE: 531398) is currently trading at ₹108.50, with a market capitalization of ₹698.41M. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio is essential for fundamental analysis.
Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio Current Value
The current Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio stands at 2.98.
The latest Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio Historical Trend
The Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 2.98
- 2023: 2.08
- 2022: 2.89
- 2021: 2.84
- 2020: 3.83
The recent rise in Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio Indicates for Investors
The Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio Analysis Summary
The Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Source Natural Foods & Herbal Supplements Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800